Skip to main content
. Author manuscript; available in PMC: 2013 Dec 1.
Published in final edited form as: Oral Oncol. 2012 Jul 20;48(12):1202–1207. doi: 10.1016/j.oraloncology.2012.06.002

Table 1.

Expression levels of EGFR, uPAR, and negative control CD19 was determined by flow cytometry. UMSCC-11B, NA-SCC, MDA-MB-231, and Caco-2 all highly express EGFR, but have negligible uPAR expression. HUVEC contained high levels of uPAR receptor as expected. The negative control antibody, HD-37FITC, bound very highly to Raji cells, a CD19 positive B-cell lymphoma line.

EGFR uPAR CD19
UMSCC-11B 100.0 1.5 0.7
NA-SCC 99.0 1.3 0.4
MDA-MB-231 91.2 1.2 1.3
HUVEC 3.7 61.2 2.8
Raji 5.6 7.7 95.8
Caco-2 98.8 .4 .8